Active migration technique in RIRS for 1- to 2-cm middle and upper ureteral stones in a prospective randomized controlled study

一项前瞻性随机对照研究探讨了逆行肾内镜手术(RIRS)中治疗1~2厘米中上段输尿管结石的主动移位技术。

阅读:2

Abstract

OBJECTIVE: This study aimed to observe the efficacy and safety of the active migration technique and in situ lithotripsy technique in retrograde intrarenal surgery (RIRS) for patients with 1- to 2-cm middle and upper ureteral stones. PATIENTS AND METHODS: Two hundred seven patients were enrolled in the study, of which 103 included in the study group received active migration lithotripsy and 104 included in the control group received in situ lithotripsy. The primary study outcome was the stone-free rate (SFR) on the first postoperative day. Secondary outcomes included the total SFR 4 weeks postoperatively, operative time, reduction in the haemoglobin levels, the length of postoperative hospital stay, the incidence of ureteral stricture at 3-month postoperatively and any surgery-related complications. RESULTS: There was no obvious difference between two groups in patients' demographics and preoperative clinical characteristics (p > 0.05). The operative time was significantly shorter in the study group than in the control group (57.1 vs. 62.5 min, p < 0.001). The study group also had significantly higher immediate and total SFRs (81.5% vs. 64.4%, p = 0.006, 90.3% vs. 77.9%, p = 0.015, respectively). At 3 months postoperatively, the incidence of ureteral stricture in the study was statistically lower than in the control group (1.0% vs. 6.7%, p = 0.032). Notablely, the overall complication rate was significantly lower in the study group than in the control group (p < 0.001). CONCLUSIONS: Our study provides evidence that the active migration technique, when combined with flexible and negative suction ureteral access sheath (FANS) in RIRS, results in a higher SFR and a lower complication rate than in situ lithotripsy for treating 1- to 2-cm middle and upper ureteral stones. The protocol for this study has been accepted by the Chinese Clinical Trial Registry (The registration number: ChiCTR2200056402; Date of registration: 03-06-2022).

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。